Table 4 Hypothetical target of several miRNA that have different expression between HCC and adjacent non-tumor

From: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues

miR-18/pre miR-18
 CTGF Connective tissue growth factor
 CCNL Cyclin L1
 IMP-2 Insulin-like growth factor-II mRNA-binding protein 2
 TAIP-2 TGF-beta induced apotosis protein 2
 EAR-7 Thyroid hormone receptor alpha
 RANKL Receptor activator of nucler factor kappa B ligand
miR-125a
 MTSG1 Mitochondrial tumor suppressor gene 1
 RARA Retinoic acid receptor alpha
miR195
 MECP2 Methyl-CPG-binding protein 2
 cSKI SKI Oncogene
 BCL2L11 BCL-2-like protein 11
miR-199a/ miR-199*
 JUNB jun B proto-oncogene
 MED6 Methyl-CPG binding domain protein 6
 MECP2 Methyl-CPG-binding protein 2
 CCNL Cyclin L
 ETS2 v-ets erythroblastosis virus E26 oncogene homolog 2
miR-200a
 RAB30 RAB30, member RAS oncogene family (RAB30), mRNA
 PCDH8 Protocadherin 8 (PCDH8), transcript variant 1, mRNA
 G3BP2 Ras-GTPase activating protein SH3 domain-binding
 TRAP2 Thyroid hormone receptor associated protein 2
miR-224
 PDGFRB Platelet-derived growth factor receptor precursor beta
 RAB9B Ras-related protein RAB-9B